When we used classifier genes indicating classical or more aggressive basal-like cancers as signatures for a GSEA [4], basal-like A and B signatures enrich in PDACs with high FRA1 mRNA expression (Fig. 2e). The gene discussed is FOSL1; the disease is cancer.